Coronary vessel formation in development and disease: mechanisms and insights for therapy

Irina-Elena Lupu1, Sarah De Val1,2, Nicola Smart3

  • 1British Heart Foundation Centre of Regenerative Medicine, Burdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.

Insights

New blood vessel formation after myocardial infarction (MI) is crucial but insufficient. Understanding developmental processes may unlock therapies for heart regeneration and neovascularization.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Developmental Biology

Background:

  • Neovascularization post-myocardial infarction (MI) is vital for cardiac tissue survival but often inadequate.
  • Insufficient revascularization leads to adverse ventricular remodeling, heart failure, and mortality.
  • Clinical trials for angiogenic therapy have yielded neutral results due to a poor understanding of functional coronary vasculature formation.

Purpose of the Study:

  • To review recent advances in understanding coronary vessel formation.
  • To provide mechanistic insights from developmental studies.
  • To highlight the importance of understanding these processes for regenerative medicine.

Main Methods:

  • Review of current literature on coronary vessel development.
  • Analysis of mechanistic insights from embryonic and adult cardiac development.
  • Comparison of developmental processes with post-injury cardiac regeneration.

Main Results:

  • Coronary vessels arise from multiple sources during development via orchestrated processes.
  • Ectopic reactivation of developmental programs is a potential regenerative medicine strategy.
  • Differences between embryonic and adult heart development offer insights into post-injury repair.

Conclusions:

  • A comprehensive understanding of coronary vessel formation is crucial for regenerative medicine.
  • Identifying how developmental processes differ and can be recapitulated post-injury is key.
  • This knowledge may identify molecular targets to promote therapeutic neovascularization and regeneration in the infarcted heart.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
270
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
771
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
169
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
1.2K